Physician Use of Non-English Language Skills in Cancer Care
1 other identifier
observational
71
1 country
5
Brief Summary
The purpose of this study is to test a method for analyzing interactions between patients and doctors, the Roter Interaction Analysis System (RIAS). The RIAS measures the quality of communication between patients and their cancer doctors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2015
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 14, 2015
CompletedFirst Submitted
Initial submission to the registry
March 15, 2016
CompletedFirst Posted
Study publicly available on registry
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 21, 2023
CompletedAugust 23, 2023
August 1, 2023
7.7 years
March 15, 2016
August 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
study-specific coding structure
using the RIAS in cancer care across English and Spanish languages will be assessed by evaluating whether this existing, validated coding system 'works' across a language barrier.
2 years
Study Arms (2)
Oncology physician
Physicians (MD or DO) in the oncology departments of participating hospitals will complete a survey. Non-English language proficiency will be assessed by self-assessment using Interagency Language Roundtable (ILR) scale, which the PI has previously used. The physician survey is collected among treating physicians of patients enrolled to MSK IRB approved protocols 12-099 and 12-223 at some of the participating hospitals. For physicians who already completed this survey as part of participation in protocol 12-099 or 12-223, data will be extracted from the respective study's REDCap database.
patients
Audio record the initial visits between patients and their treating physician. Analyze 48 patient-physician dyad recordings using the Roter Interaction Analysis System (RIAS).
Interventions
The ILR Scale, a non-English language proficiency self-assessment.
Audio record the initial visits between patients and their treating physician
Eligibility Criteria
The study will enroll all treating physicians of participating sites who are likely to treat LEP Spanish-speaking patients. All patient recruitment will be done by bilingual research staff who are consenting professionals with (when necessary) a volunteer affiliation with the collaborating study site.
You may qualify if:
- is a English or Spanish-speaking patient
- between the ages of 21-80 years old
- has a new diagnosis of any type of cancer (diagnosed within the past 4 months), or has a recurrence of either breast, colon or lung cancer (recurrence diagnosed within the past 4 months)
- scheduled to have surgery or begin chemotherapy and/or radiation therapy within the next 2 months
- provides care to LEP patients
- has MD, DO, RN, NP or PA degree
- is between the ages of 21-80
You may not qualify if:
- is unable to provide informed consent in either English or Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Memorial Sloan Kettering Cancer Centerlead
- Edward-Elmhurst Health Systemcollaborator
- Johns Hopkins Universitycollaborator
- Lincoln Medical and Mental Health Centercollaborator
- Queens Cancer Center of Queens Hospitalcollaborator
Study Sites (5)
Queens Cancer Center of Queens Hospital
Jamaica, New York, 11432, United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Ralph Lauren Center for Cancer Care and Prevention
New York, New York, United States
Elmhurst Hospital Center
Queens, New York, 11373, United States
Lincoln Medical Center
The Bronx, New York, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Diamond, MD, MPH
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2016
First Posted
April 1, 2016
Study Start
December 14, 2015
Primary Completion
August 21, 2023
Study Completion
August 21, 2023
Last Updated
August 23, 2023
Record last verified: 2023-08